vidarabine has been researched along with Experimental Neoplasms in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (57.89) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Driscoll, JS; Kaskar, B; Khan, MS; Lim, MI; Markovac, A; Marquez, VE; Plowman, J; Priest, MA; Treanor, SP | 1 |
| Appelhans, D; Borowiec, M; Bryszewska, M; Danilewicz, M; Franiak-Pietryga, I; Jander, M; Kuncman, W; Sikorska, H; Ziemba, B | 1 |
| Appelhans, D; Borowiec, M; Bryszewska, M; Danilewicz, M; Franiak-Pietryga, I; Jander, M; Kuncman, W; Lewkowicz, P; Ostrowska, K; Sikorska, H; Ziemba, B | 1 |
| Biondi, A; Corsi, A; Dazzi, F; Granata, V; Michelozzi, IM; Pievani, A; Rambaldi, B; Serafini, M | 1 |
| Castejon, R; Losada-Fernandez, I; Martinez, A; Morado, M; Perez-Aciego, P; Perez-Chacon, G; Rebolleda, N; Rosado, S; Vallejo-Cremades, MT; Vargas-Nuñez, JA | 1 |
| BRINK, JJ; LEPAGE, GA | 2 |
| Aprahamian, M; Deharvengt, S; Hajri, A; Rejiba, S; Wack, S | 1 |
| Cohen, T; Manor, D; Margalith, M | 1 |
| Balis, ME; Dunzendorfer, U; Kleinert, E; Relyea, NM; Whitmore, WF | 1 |
| Kada, T; Nakatsugawa, S; Nikaido, O; Sugahara, T; Tanaka, Y | 1 |
| Akagi, K; Sogawa, M; Tanaka, Y | 1 |
| Faulds, D; McTavish, D; Ross, SR | 1 |
| Brock, WA; Grégoire, V; Hittelman, WN; Hunter, N; Milas, L; Plunkett, W | 1 |
| Brock, WA; Grégoire, V; Hittelman, WN; Milas, L; Plunkett, W; Stephens, LC; Van, NT | 1 |
| Drach, JC; Sandberg, JN; Shipman, C | 1 |
| Maidhof, A; Müller, WE; Shannon, WM; Zahn, RK | 1 |
| Breitman, TR; Cooney, DA; Dalal, M; del Campo, AA; Driscoll, JS; Johns, DG; Plowman, J; Schuller, HM; Vistica, DT | 1 |
| LePage, GA | 1 |
1 review(s) available for vidarabine and Experimental Neoplasms
| Article | Year |
|---|---|
Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.
Topics: Animals; Antineoplastic Agents; Humans; Neoplasms; Neoplasms, Experimental; Vidarabine | 1993 |
18 other study(ies) available for vidarabine and Experimental Neoplasms
| Article | Year |
|---|---|
Cyclopentenylcytosine. A carbocyclic nucleoside with antitumor and antiviral properties.
Topics: 3-Deazauridine; Animals; Antineoplastic Agents; Antiviral Agents; Chemical Phenomena; Chemistry; Cytidine; DNA Viruses; Humans; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Orthomyxoviridae; RNA Viruses; Sarcoma, Experimental; Viruses | 1988 |
Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Marrow; Cell Line, Tumor; Dendrimers; Drug Development; Heterografts; Humans; Immunotherapy; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Neoplasms, Experimental; Polypropylenes; Tissue Distribution; Trisaccharides; Vidarabine | 2020 |
Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
Topics: Animals; Cell Line, Tumor; Dendrimers; Drug Delivery Systems; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Mice; Mice, Inbred NOD; Neoplasms, Experimental; Pilot Projects; Polypropylenes; Trisaccharides; Vidarabine | 2020 |
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice.
Topics: Animals; Cell Line, Tumor; Graft Survival; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Humans; Mice; Mice, SCID; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation Conditioning; Vidarabine | 2018 |
Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model.
Topics: Age Factors; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Cells, Cultured; Drug Synergism; Female; Humans; Immunoblotting; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Leukocytes, Mononuclear; Mice, Inbred NZB; Neoplasms, Experimental; NF-kappa B; Proto-Oncogene Proteins c-akt; Rotenone; Signal Transduction; Tumor Cells, Cultured; Vidarabine | 2016 |
METABOLISM AND DISTRIBUTION OF 9-BETA-D-ARABINOFURANOSYLADENINE IN MOUSE TISSUES.
Topics: Animals; Antineoplastic Agents; DNA; DNA, Neoplasm; Leukemia L1210; Leukocytes; Liver; Mice; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Research; RNA; RNA, Neoplasm; Urine; Vidarabine | 1964 |
9-BETA-D-ARABINOFURANOSYLADENINE AS AN INHIBITOR OF METABOLISM IN NORMAL AND NEOPLASTIC CELLS.
Topics: Carbon Isotopes; DNA; DNA, Neoplasm; Injections, Intraperitoneal; Liver; Metabolism; Mice; Neoplasms; Neoplasms, Experimental; Nucleosides; Pharmacology; Proteins; Purines; Radiometry; Research; RNA; RNA, Neoplasm; Vidarabine | 1965 |
Efficient electrogene therapy for pancreatic adenocarcinoma treatment using the bacterial purine nucleoside phosphorylase suicide gene with fludarabine.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Electrochemotherapy; Electroporation; Gene Transfer Techniques; Genes, Bacterial; Genes, Transgenic, Suicide; Genetic Therapy; Humans; Neoplasms, Experimental; Pancreatic Neoplasms; Prodrugs; Purine-Nucleoside Phosphorylase; Rats; Rats, Inbred Lew; RNA, Messenger; Vidarabine; Xenograft Model Antitumor Assays | 2007 |
Cytotoxicity of arabinofuranosyladenine and erythro-9-(2-hydroxy-3-nonyl) adenine to Epstein-Barr virus producer and nonproducer lymphoma cells in culture.
Topics: Adenine; Animals; Burkitt Lymphoma; Callitrichinae; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Genes, Viral; Herpesvirus 4, Human; Humans; Infectious Mononucleosis; Neoplasms, Experimental; Vidarabine | 1983 |
Antigrowth effect of some inhibitors of polyamine synthesis on transplantable prostate cancer.
Topics: Animals; Body Weight; Drug Therapy, Combination; Eflornithine; Guanidines; Male; Mitoguazone; Neoplasm Transplantation; Neoplasms, Experimental; Ornithine; Polyamines; Prostatic Neoplasms; Rats; Vidarabine | 1983 |
PLDR inhibitors: their biological and clinical implications.
Topics: Animals; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Cyclophosphamide; Deoxyadenosines; Deoxyguanosine; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Nucleosides; Time Factors; Vidarabine | 1984 |
[Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
Topics: Animals; Cell Line; Cell Survival; Cyclophosphamide; Doxorubicin; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasms, Experimental; Radiation-Sensitizing Agents; Sarcoma, Experimental; Vidarabine | 1983 |
Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation.
Topics: Animals; Antineoplastic Agents; Male; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage; Vidarabine | 1994 |
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; DNA; Dose-Response Relationship, Drug; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Radiation Tolerance; S Phase; Vidarabine | 1994 |
Antiproliferative effects of 9-beta-d-arabinofuranosyladenine in a mammalian cell line devoid of adenosine deaminase activity.
Topics: Adenosine Deaminase; Animals; Cell Division; Cell Line; Cells, Cultured; DNA; Mitosis; Neoplasms, Experimental; Rats; RNA; Sarcoma, Avian; Vidarabine | 1977 |
Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
Topics: Adenosine Deaminase; Adenosine Triphosphate; Arabinose; Binding, Competitive; Cell Division; Cells, Cultured; Deoxyadenosines; DNA-Directed RNA Polymerases; DNA, Neoplasm; Lymphoma; Neoplasms, Experimental; Nucleic Acid Synthesis Inhibitors; Vidarabine | 1977 |
Arabinofuranosyl-5-azacytosine: antitumor and cytotoxic properties.
Topics: Animals; Azacitidine; Cell Cycle; Cell Differentiation; Cell Survival; Cells, Cultured; Humans; Mice; Microscopy, Electron; Neoplasm Transplantation; Neoplasms, Experimental; Vidarabine | 1986 |
Manipulation of DNA synthesis in normal and neoplastic tissues with drugs.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Carcinoma, Ehrlich Tumor; Cell Line; Cytarabine; Deoxyribonucleosides; DNA; DNA, Neoplasm; Female; Mice; Neoplasms, Experimental; Thioguanine; Time Factors; Vidarabine | 1974 |